Danh mục

Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors

Số trang: 8      Loại file: pdf      Dung lượng: 1.02 MB      Lượt xem: 11      Lượt tải: 0    
Xem trước 1 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Accumulating evidence has revealed that the gut microbiota influences the effectiveness of immune checkpoint inhibitors (ICIs) in cancer patients. As a part of the human microbiome, Helicobacter pylori (H. pylori) was reported to be associated with reduced effectiveness of anti-PD1 immunotherapy in patients with non-small-cell lung cancer (NSCLC).
Nội dung trích xuất từ tài liệu:
Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors

Tài liệu được xem nhiều: